false0000849146 0000849146 2019-08-14 2019-08-14

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 ______________________________

 FORM 8-K

 ______________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 14, 2019

 ______________________________

LIFEVANTAGE CORPORATION

(Exact name of registrant as specified in its charter)

______________________________

Delaware		001-35647			90-0224471
(State or other jurisdiction of incorporation or organization)		(Commission File Number)			(IRS Employer Identification No.)

9785 S. Monroe Street, Suite 400

Sandy, Utah 84070

(Address of principal executive offices, including zip code)

(801) 432-9000

Registrant's telephone number

_____________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Common Stock, par value $0.0001		LFVN		The Nasdaq Stock Market LLC
Title of each class		Trading Symbol(s)		Name of each exchange on which registered

Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

---

Item 2.02.    Results of Operations and Financial Condition.

On August 14, 2019, LifeVantage Corporation (the “Company”) issued a press release announcing its financial results for the fourth quarter and full fiscal year ended June 30, 2019. A copy of the Company’s press release is attached as Exhibit 99.1 to this report and incorporated by reference.

The information furnished in this Item 2.02 and the exhibit hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01.    Financial Statements and Exhibits.

(d)    Exhibits

Exhibit No.			Description
99.1			Press Release issued by the Company on August 14, 2019, announcing its financial results for the fourth quarter and full fiscal year ended June 30, 2019.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date:	August 14, 2019	LIFEVANTAGE CORPORATION
	By:	/s/ Steven R. Fife
	Name:	Steven R. Fife
	Title:	Chief Financial Officer

•	Revenue increased 4.0% to $56.2 million year over year;

•	Revenue in the Americas decreased 2.9% year over year, while revenue in Asia/Pacific & Europe increased 24.4% year over year;

•	Active members increased 3.4% to 185,000, including 4.8% growth of independent distributors and a 2.6% increase in active customers, each on a year over year basis;

•	Adjusted EBITDA increased 48.6% to $7.7 million year over year;

•	Earnings per diluted share were $0.26, compared to $0.21 in the prior year period; and

•	Adjusted earnings per diluted share were $0.26, compared to $0.20 in the prior year period.

•	Revenue increased 11.2% to $226.0 million;

•	Revenue in the Americas increased 7.7% and revenue in Asia/Pacific & Europe increased 21.6%;

•	Adjusted EBITDA increased 22.4% to $18.2 million;

•	Earnings per diluted share were $0.50, compared to $0.41 in fiscal 2018;

•	Adjusted earnings per diluted share were $0.59, compared to $0.51 in fiscal 2018; and

•	Repurchased 389,000, or $4.7 million, of common shares, and paid down $4.0 million of long-term debt, reflecting strong cash flow from operations of $17.8 million.

---

---

---

---

---

---

---

---

---